Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years
Public ClinicalTrials.gov record NCT07521371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Observational Study of Intranasal Insulin Delivery in Autism Spectrum Disorder Ages 4 to 21 Years (INS-AUT)
Study identification
- NCT ID
- NCT07521371
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Healing Hope International
- Other
- Enrollment
- 12 participants
Conditions and interventions
Conditions
- Autism Spectrum Disorder
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder High-Functioning
- Autism Spectrum Disorder With Absence of Functional Language
- Autism Spectrum Disorder With Impaired Functional Language
- Autistic Disorder
- Autistic Disorder in Children and Adolescents
- Autistic Disorder of Childhood Onset With Full Syndrome
- Autistic Disorders Spectrum
- Neurodevelopmental Disorders
- Neurodevelopmental Disorders (NDD)
- Neurodevelopmental Disorders and Developmental Abnormalities
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 4 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2026
- Primary completion
- Dec 30, 2028
- Completion
- Jan 29, 2030
- Last update posted
- Apr 8, 2026
2026 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Healing Hope International | Spring | Texas | 77386 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07521371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07521371 live on ClinicalTrials.gov.